167 related articles for article (PubMed ID: 25867449)
1. Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen.
Donadei A; Gallorini S; Berti F; O'Hagan DT; Adamo R; Baudner BC
Mol Pharm; 2015 May; 12(5):1662-72. PubMed ID: 25867449
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan.
Lipinski T; Fitieh A; St Pierre J; Ostergaard HL; Bundle DR; Touret N
J Immunol; 2013 Apr; 190(8):4116-28. PubMed ID: 23514738
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
4. Laminarin-mediated targeting to Dectin-1 enhances antigen-specific immune responses.
Xie J; Guo L; Ruan Y; Zhu H; Wang L; Zhou L; Yun X; Gu J
Biochem Biophys Res Commun; 2010 Jan; 391(1):958-62. PubMed ID: 19962962
[TBL] [Abstract][Full Text] [Related]
5. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine.
Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R
Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628
[TBL] [Abstract][Full Text] [Related]
6. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.
Adams EL; Rice PJ; Graves B; Ensley HE; Yu H; Brown GD; Gordon S; Monteiro MA; Papp-Szabo E; Lowman DW; Power TD; Wempe MF; Williams DL
J Pharmacol Exp Ther; 2008 Apr; 325(1):115-23. PubMed ID: 18171906
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
Qiao W; Ji S; Zhao Y; Hu T
Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
Berner VK; Sura ME; Hunter KW
Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
[TBL] [Abstract][Full Text] [Related]
9. β-glucans as potential immunoadjuvants: A review on the adjuvanticity, structure-activity relationship and receptor recognition properties.
Jin Y; Li P; Wang F
Vaccine; 2018 Aug; 36(35):5235-5244. PubMed ID: 30049632
[TBL] [Abstract][Full Text] [Related]
10. Characterization of beta-glucan recognition site on C-type lectin, dectin 1.
Adachi Y; Ishii T; Ikeda Y; Hoshino A; Tamura H; Aketagawa J; Tanaka S; Ohno N
Infect Immun; 2004 Jul; 72(7):4159-71. PubMed ID: 15213161
[TBL] [Abstract][Full Text] [Related]
11. Binding assay of human Dectin-1 variants to DNA/β-glucan complex for active-targeting delivery of antisense DNA.
Fujiwara N; Izumi H; Kira R; Morimoto Y; Mochizuki S; Sakurai K
Carbohydr Res; 2021 Feb; 500():108219. PubMed ID: 33339585
[TBL] [Abstract][Full Text] [Related]
12. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling and docking characterization of Dectin-1 (PAMP) receptor of Bubalus bubalis.
Yadav BS; Tripathi V; Kumar A; Khan MF; Barate A; Kumar A; Sharma B
Exp Mol Pathol; 2012 Feb; 92(1):7-12. PubMed ID: 22015804
[TBL] [Abstract][Full Text] [Related]
14. Designing an immunocyte-targeting delivery system by use of beta-glucan.
Miyamoto N; Mochizuki S; Sakurai K
Vaccine; 2018 Jan; 36(1):186-189. PubMed ID: 29174675
[TBL] [Abstract][Full Text] [Related]
15. Beta-Glucan Particles as Vaccine Adjuvant Carriers.
Mirza Z; Soto ER; Dikengil F; Levitz SM; Ostroff GR
Methods Mol Biol; 2017; 1625():143-157. PubMed ID: 28584989
[TBL] [Abstract][Full Text] [Related]
16. The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan.
Quayle K; Coy C; Standish L; Lu H
J Nat Med; 2015 Apr; 69(2):198-208. PubMed ID: 25510899
[TBL] [Abstract][Full Text] [Related]
17. Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides.
Palma AS; Feizi T; Zhang Y; Stoll MS; Lawson AM; Díaz-Rodríguez E; Campanero-Rhodes MA; Costa J; Gordon S; Brown GD; Chai W
J Biol Chem; 2006 Mar; 281(9):5771-9. PubMed ID: 16371356
[TBL] [Abstract][Full Text] [Related]
18. Binding assay between murine Dectin-1 and β-glucan/DNA complex with quartz-crystal microbalance.
Mochizuki S; Morishita H; Adachi Y; Yamaguchi Y; Sakurai K
Carbohydr Res; 2014 Jun; 391():1-8. PubMed ID: 24732035
[TBL] [Abstract][Full Text] [Related]
19. A convenient assay for soluble Dectin-1 lectin domain binding to insoluble β-glucans.
Chiba H; Manabe N; Naito J; Nishida N; Ohno N; Yamaguchi Y
Carbohydr Res; 2024 Feb; 536():109041. PubMed ID: 38262208
[TBL] [Abstract][Full Text] [Related]
20. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants.
Lu F; Mencia A; Bi L; Taylor A; Yao Y; HogenEsch H
J Control Release; 2015 Apr; 204():51-9. PubMed ID: 25747143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
